US Patent Issued to SHENZHEN PHARMACIN on July 8 for "Pharmaceutical compositions of PROTAC compounds and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,268, issued on July 8, was assigned to SHENZHEN PHARMACIN Co. LTD. (Shenzhen, China).

"Pharmaceutical compositions of PROTAC compounds and uses thereof" was invented by Zeren Wang (Shenzhen, China) and Shun Chen (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Proteolysis Targeting Chimeras (PROTACs) are heterobifunctional degraders that specifically eliminate targeted proteins by hijacking the ubiquitin-proteasome system (UPS). Provided are pharmaceutical compositions which include a mixture of a PROTAC, a hydrophilic polymer, a surfactant, and optionally an acid and an adsorbent. Also described are methods for preparing and using suc...